FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3086914933> ?p ?o ?g. }

• W3086914933 endingPage "650" @default.
• W3086914933 startingPage "643" @default.
• W3086914933 abstract "To assist the Malawi Ministry of Health to evaluate 2 competing strategies for scale-up of isoniazid preventive therapy (IPT) among HIV-positive adults receiving antiretroviral therapy.Malawi.We used a multidistrict, compartmental model of the Malawi tuberculosis (TB)/HIV epidemic to compare the anticipated health impacts of 6-month versus continuous IPT programs over a 12-year horizon while respecting a US$10.8 million constraint on drug costs in the first 3 years.The 6-month IPT program could be implemented nationwide, whereas the continuous IPT alternative could be introduced in 14 (of the 27) districts. By the end of year 12, the continuous IPT strategy was predicted to avert more TB cases than the 6-month alternative, although not statistically significant (2368 additional cases averted; 95% projection interval [PI], -1459 to 5023). The 6-month strategy required fewer person-years of IPT to avert a case of TB or death than the continuous strategy. For both programs, the mean reductions in TB incidence among people living with HIV by year 12 were expected to be <10%, and the cumulative numbers of IPT-related hepatotoxicity to exceed the number of all-cause deaths averted in the first 3 years.With the given budgetary constraint, the nationwide implementation of 6-month IPT would be more efficient and yield comparable health benefits than implementing a continuous IPT program in fewer districts. The anticipated health effects associated with both IPT strategies suggested that a combination of different TB intervention strategies would likely be required to yield a greater impact on TB control in settings such as Malawi, where antiretroviral therapycoverage is relatively high." @default.
• W3086914933 created "2020-09-21" @default.
• W3086914933 creator A5009781874 @default.
• W3086914933 creator A5014684951 @default.
• W3086914933 creator A5014819735 @default.
• W3086914933 creator A5020104507 @default.
• W3086914933 creator A5022417092 @default.
• W3086914933 creator A5033519595 @default.
• W3086914933 creator A5034483496 @default.
• W3086914933 creator A5035898453 @default.
• W3086914933 creator A5044663594 @default.
• W3086914933 creator A5051682565 @default.
• W3086914933 creator A5059135593 @default.
• W3086914933 creator A5064630251 @default.
• W3086914933 creator A5068219287 @default.
• W3086914933 creator A5075482692 @default.
• W3086914933 creator A5082249530 @default.
• W3086914933 creator A5085827689 @default.
• W3086914933 creator A5087136833 @default.
• W3086914933 creator A5089201387 @default.
• W3086914933 creator A5089279556 @default.
• W3086914933 date "2020-12-15" @default.
• W3086914933 modified "2023-09-29" @default.
• W3086914933 title "Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi" @default.
• W3086914933 cites W115853544 @default.
• W3086914933 cites W127803786 @default.
• W3086914933 cites W154273085 @default.
• W3086914933 cites W1987443112 @default.
• W3086914933 cites W1989219811 @default.
• W3086914933 cites W1999825734 @default.
• W3086914933 cites W2002935662 @default.
• W3086914933 cites W2006773444 @default.
• W3086914933 cites W2015386250 @default.
• W3086914933 cites W2018544228 @default.
• W3086914933 cites W2075884078 @default.
• W3086914933 cites W2081418446 @default.
• W3086914933 cites W2098054976 @default.
• W3086914933 cites W2142064497 @default.
• W3086914933 cites W2152022540 @default.
• W3086914933 cites W2166112014 @default.
• W3086914933 cites W2207678994 @default.
• W3086914933 cites W2240173975 @default.
• W3086914933 cites W2301644787 @default.
• W3086914933 cites W2512452351 @default.
• W3086914933 cites W2534434122 @default.
• W3086914933 cites W2737029031 @default.
• W3086914933 cites W2763260404 @default.
• W3086914933 cites W2897213288 @default.
• W3086914933 doi "https://doi.org/10.1097/qai.0000000000002497" @default.
• W3086914933 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8564780" @default.
• W3086914933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33177475" @default.
• W3086914933 hasPublicationYear "2020" @default.
• W3086914933 type Work @default.
• W3086914933 sameAs 3086914933 @default.
• W3086914933 citedByCount "3" @default.
• W3086914933 countsByYear W30869149332021 @default.
• W3086914933 countsByYear W30869149332022 @default.
• W3086914933 crossrefType "journal-article" @default.
• W3086914933 hasAuthorship W3086914933A5009781874 @default.
• W3086914933 hasAuthorship W3086914933A5014684951 @default.
• W3086914933 hasAuthorship W3086914933A5014819735 @default.
• W3086914933 hasAuthorship W3086914933A5020104507 @default.
• W3086914933 hasAuthorship W3086914933A5022417092 @default.
• W3086914933 hasAuthorship W3086914933A5033519595 @default.
• W3086914933 hasAuthorship W3086914933A5034483496 @default.
• W3086914933 hasAuthorship W3086914933A5035898453 @default.
• W3086914933 hasAuthorship W3086914933A5044663594 @default.
• W3086914933 hasAuthorship W3086914933A5051682565 @default.
• W3086914933 hasAuthorship W3086914933A5059135593 @default.
• W3086914933 hasAuthorship W3086914933A5064630251 @default.
• W3086914933 hasAuthorship W3086914933A5068219287 @default.
• W3086914933 hasAuthorship W3086914933A5075482692 @default.
• W3086914933 hasAuthorship W3086914933A5082249530 @default.
• W3086914933 hasAuthorship W3086914933A5085827689 @default.
• W3086914933 hasAuthorship W3086914933A5087136833 @default.
• W3086914933 hasAuthorship W3086914933A5089201387 @default.
• W3086914933 hasAuthorship W3086914933A5089279556 @default.
• W3086914933 hasBestOaLocation W30869149331 @default.
• W3086914933 hasConcept C142724271 @default.
• W3086914933 hasConcept C144024400 @default.
• W3086914933 hasConcept C149923435 @default.
• W3086914933 hasConcept C187212893 @default.
• W3086914933 hasConcept C2776967927 @default.
• W3086914933 hasConcept C2781069245 @default.
• W3086914933 hasConcept C71924100 @default.
• W3086914933 hasConcept C99454951 @default.
• W3086914933 hasConceptScore W3086914933C142724271 @default.
• W3086914933 hasConceptScore W3086914933C144024400 @default.
• W3086914933 hasConceptScore W3086914933C149923435 @default.
• W3086914933 hasConceptScore W3086914933C187212893 @default.
• W3086914933 hasConceptScore W3086914933C2776967927 @default.
• W3086914933 hasConceptScore W3086914933C2781069245 @default.
• W3086914933 hasConceptScore W3086914933C71924100 @default.
• W3086914933 hasConceptScore W3086914933C99454951 @default.
• W3086914933 hasIssue "5" @default.
• W3086914933 hasLocation W30869149331 @default.
• W3086914933 hasLocation W30869149332 @default.
• W3086914933 hasLocation W30869149333 @default.

• next